Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
about
New and emerging disease modifying therapies for multiple sclerosisTASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system.Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice.Sodium MRI of multiple sclerosis.Emerging therapies in multiple sclerosis.Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosisMolecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchangerOral administration of PF-01247324, a subtype-selective Nav1.8 blocker, reverses cerebellar deficits in a mouse model of multiple sclerosisImmunopathogenesis and immunotherapeutic approaches in multiple sclerosis.Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosisSodium channels and multiple sclerosis: roles in symptom production, damage and therapy.Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis?Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers.Synthesis and evaluation of a 125I-labeled iminodihydroquinoline-derived tracer for imaging of voltage-gated sodium channels.Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.Advancement of therapies for neuroprotection in multiple sclerosis.Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis.An animal model of cortical and callosal pathology in multiple sclerosis.Approaches to neuroprotective strategies in multiple sclerosis.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Mitochondria as crucial players in demyelinated axons: lessons from neuropathology and experimental demyelination.Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.Sodium channels in astroglia and microglia.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Phenytoin: neuroprotection or neurotoxicity?Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders.Regulation of podosome formation in macrophages by a splice variant of the sodium channel SCN8A.Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivoA recoverable state of axon injury persists for hours after spinal cord contusion in vivo.A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis.Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.Experimental autoimmune encephalomyelitis from a tissue energy perspective.Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.Regulation and dysregulation of axon infrastructure by myelinating glia.Phenytoin: its potential as neuroprotective and retinoprotective drug.Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5.Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation.Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
P2860
Q22242305-C00F5544-BB8C-48B4-B83E-569DFD67FF03Q30433284-36905FC4-DC4A-418D-AF79-AFC871B92F5AQ30478676-D7C04434-AAA8-406D-92CE-E32CF10CE30EQ30926519-75635D31-FE91-4797-BEDF-F7954F07D2DDQ31015100-69B7D808-4752-444F-9E0A-57D9553BC23CQ33919516-EEFDBADC-B266-47A4-9BC9-0B1E95A57C87Q34156496-AEB97325-B42E-44EC-85F4-CC83EFC6C877Q34321453-0F41759A-2866-4D10-994C-C76871CD51DAQ35572913-DF086737-EE23-4A7C-9A67-9D943EBD1113Q36153387-E2182237-3D69-44E2-B62D-F5B55443AF5EQ36695714-23C4093A-EE04-4323-A585-E120F7AAB38EQ36771880-DF25417A-6F41-49CB-8C6F-ADDE0E380477Q36945991-064EF09C-1A8E-4C34-BDB2-9A052158136AQ36979460-FB542A4A-234A-458F-92AF-687DB3318E60Q37150361-C27265BA-4C8B-4026-8DFC-B045C961C568Q37161778-C041631A-F1D1-4A89-8381-C642FD30050EQ37256701-F62C8EB9-EC06-4124-A9BD-E4BBF54AC0B2Q37417523-4AD2ED1F-5DF9-43CC-ABAB-D58E3E20F3B0Q37584143-BB342706-B4E0-4FB2-B6CE-012224B0DADFQ37778062-77F12794-6DCF-467F-B6D8-FEA64E1540EBQ37800214-6600DA96-180E-40D4-B6F1-3B7CF2F0E403Q37844421-1551C58A-A923-476C-8274-A8220342B2E3Q38167251-E64148A7-2E92-4231-A441-908B94490CF2Q38196701-6210940E-D6E9-4DD2-802B-63DB5F7A003AQ38751614-73B4B7D9-BB87-4024-98BD-1DFBFC747BF8Q38837294-8F34744E-CD0A-4C2F-B0C1-4F3D33749E33Q39301693-BF610315-9115-4558-BB74-3051E67681C2Q39437479-CDCC8A5D-6D90-4D95-A004-5AA1F2952726Q39896695-58C2C93B-19CE-40A6-B488-FFFD8FAB5231Q40819221-90A78D40-FD2B-4EDA-9075-982D7A0A2E8AQ41686038-3E130D6C-0B37-4ADD-B1E7-0B7DA0849A75Q43773926-33B37CB0-5C6A-4B98-845B-557261A33FDEQ45902330-FBC8ABA9-C0BD-4496-A3E2-822270030820Q46255661-272432A2-6C17-420A-BC09-580BE0E65DFFQ46490485-D608395D-6C4B-43C7-A3A6-A4E3993A6712Q46614637-6C10600E-4F78-47FB-ABCC-2B4774FADFF4Q48193596-42E68375-657A-4981-8605-56D545B36E15Q48312558-1D67D270-3DE7-4513-AE11-47A30B8F8FE1Q48686306-D01A21DC-F214-4994-8B5D-81696FAFA7B7Q48959605-846461CF-1C92-4C93-99EF-8F84F7F2553C
P2860
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@en
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@nl
type
label
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@en
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@nl
prefLabel
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@en
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@nl
P2093
P2860
P356
P1476
Phenytoin protects spinal cord ...... of neuroinflammation in vivo.
@en
P2093
Albert C Lo
Carl Y Saab
Joel A Black
Stephen G Waxman
P2860
P304
P356
10.1152/JN.00434.2003
P407
P577
2003-08-06T00:00:00Z